These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37220237)

  • 1. Cerebellar Hypermetabolism in a Hodgkin Lymphoma Leads to Diagnosis of Paucisymptomatic Cryptococcus neoformans Meningitis.
    Vanerwegen E; Ahmadi Bidakhvidi N; Vergote VKJ; Janssens A; Deroose CM
    Clin Nucl Med; 2023 Aug; 48(8):e374-e376. PubMed ID: 37220237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma-associated paraneoplastic cerebellar degeneration on FDG-PET/CT.
    Gheysens O; Deroose CM; Tousseyn T; Goffin K; Verhoef G; Dierickx D
    Br J Haematol; 2014 Feb; 164(4):468. PubMed ID: 24460525
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration.
    Choi KD; Kim JS; Park SH; Kim YK; Kim SE; Smitt PS
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):525-8. PubMed ID: 16543536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune cerebellar hypermetabolism: Report of three cases and literature overview.
    Brunet de Courssou JB; Castilla-Lievre MA; Maillot J; Brechemier ML; Ohlmann C; Sallansonnet-Froment M; Tafani C; Psimaras D; Ricard D; Bompaire F; Taifas I
    Rev Neurol (Paris); 2022 Apr; 178(4):337-346. PubMed ID: 34657731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic Cerebellar Syndrome Presented as Cerebellar Hypermetabolism in a Patient With Occult Breast Carcinoma.
    Booij J; Adam JA; van Eerde MS; Bronner IM
    Clin Nucl Med; 2022 Feb; 47(2):130-132. PubMed ID: 35006107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
    Thapa P; Basu S
    J Nucl Med Technol; 2016 Mar; 44(1):52-3. PubMed ID: 26271804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar Hypermetabolism in a Case of Paraneoplastic Cerebellar Syndrome With the Primary Lymphoepithelial Carcinoma in Tonsil.
    Wang J; Wang W; Zhao Y; Cui R
    Clin Nucl Med; 2019 Oct; 44(10):812-814. PubMed ID: 31162262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar hypermetabolism on ¹⁸F-FDG PET/CT with normal MRI in a case of paraneoplastic cerebellar degeneration with negative antibodies.
    Sharma P; Mazumdar B; Chatterjee P
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):79-80. PubMed ID: 25001850
    [No Abstract]   [Full Text] [Related]  

  • 9. 18F-FDG PET/CT Imaging of Hodgkin Lymphoma in a Child with Common Variable Immunodeficiency.
    Tatci E; Biner IU; Tanyildiz HG; Ozmen O; Gokcek A; Sahin G; Tazeler Z
    J Nucl Med Technol; 2016 Dec; 44(4):259-260. PubMed ID: 27363447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report.
    Abdulaziz ATA; Yu XQ; Zhang L; Jiang XY; Zhou D; Li JM
    Medicine (Baltimore); 2018 Jun; 97(24):e10717. PubMed ID: 29901574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT in assessment of paraneoplastic cerebellar degeneration as the first sign of occult fallopian tube serous cystadenocarcinoma: Case report.
    Kalantari F; Schweighofer-Zwink G; Hecht S; Rendl G; Pirich C; Beheshti M
    Rofo; 2024 Aug; 196(8):850-851. PubMed ID: 38626884
    [No Abstract]   [Full Text] [Related]  

  • 13. Hodgkin's lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature.
    Gungor S; Kilic B; Arslan M; Ozgen U
    Childs Nerv Syst; 2017 Mar; 33(3):509-512. PubMed ID: 27796550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET hypermetabolism in paraneoplastic cerebellar degeneration.
    Castelnovo G; Wacongne ; Collombier L; Renard D; Labauge P
    Acta Neurol Belg; 2011 Jun; 111(2):165. PubMed ID: 21748944
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates.
    Basu S; Alavi A
    Mol Imaging Biol; 2008; 10(3):131-7. PubMed ID: 18297363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report.
    Inui R; Saito K; Shimomura Y; Yamashita D; Kawamoto M; Ishikawa T
    BMC Neurol; 2020 Sep; 20(1):355. PubMed ID: 32967629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive Intraspinal Hypermetabolism Caused by Neurobrucellosis Shown on 18F-FDG PET/CT.
    Wu M; Cui R; Li F; Huo L; Luo Y
    Clin Nucl Med; 2020 Sep; 45(9):722-724. PubMed ID: 32404712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAC y PET/TC con 18-FDG para evaluar la respuesta al tratamiento en linfoma de Hodgkin y no Hodgkin.
    Vargas-Partida T; Hernández-Cruz M; Ruiz-Eng R; Montiel-Jarquín ÁJ; Vázquez-Cruz E; López-Colombo A
    Gac Med Mex; 2019; 155(4):386-390. PubMed ID: 31486785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
    Flanagan EP; Hunt CH; Lowe V; Mandrekar J; Pittock SJ; O'Neill BP; Keegan BM
    Mayo Clin Proc; 2013 Nov; 88(11):1204-12. PubMed ID: 24182701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.